(Reuters) -Buyout firm Thoma Bravo is exploring a $3 billion-plus sale of Apryse, after receiving interest from potential buyers of the document processing software provider, people familiar with ...

Mission: Impossible – The Final Reckoning Box Office: Will Tom Cruise’s Magnum Opus Be A Success Despite Its $350 Million+ Budget? Tom Cruise's Mission: Impossible - The Final Reckoning is ...

UAE – Al Zorah Development Company, a joint venture between the Government of Ajman and Solidere International, has signed with MAG Group Holding, a multinational conglomerate with diversified ...

You should already have an eye on next season while still managing the day-to-day operations of your current squad (s). But not everyone has the bandwidth to go through the process without a bit of ...

Private equity firm Thoma Bravo has sold its remaining stake in Nasdaq for approximately $3.4 billion in two separate transactions, a source familiar with the matter told Reuters on Thursday.

Thoma Bravo just wrapped up a two-year trade with a bangoffloading its remaining 43 million shares in Nasdaq (NASDAQ:NDAQ) for roughly $3.4 billion. The private equity firm sold the shares in two ...

Sunday afternoon’s match ended Newcastle 2 Chelsea 0. Ahead of each game we ask one of our writers to come up with three positives and three negatives following the game. An interesting ...

Former 'Real Housewives of Atlanta' star Kandi Burruss shares one child with ex Russell Spencer and two with Todd Tucker. Here’s everything to know about Kandi Burruss’ kids.

Bravo Le Roux Inks New Tattoo To Celebrate Igazi, Iinyembezi, Nombilo Album Success ...

MAG has signed a $3bn tokenisation agreement with MultiBank Group and Mavryk. The collaboration between the Dubai real estate developer, financial derivatives institution and blockchain innovator ...

Instagram Threads, Meta’s X competitor, has now grown to over 350 million monthly active users, CEO Mark Zuckerberg revealed during the company’s Q1 2025 earnings call on Wednesday. That’s ...

Walgreen Co. will pay the US government and whistleblowers at least $300 million to settle a False Claims Act suit alleging that the company billed federal health-care programs for prescriptions that ...